Compounds > lorazepam

lorazepam and pk 11195

lorazepam has been researched along with pk 11195 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Byrnes, JJ; Galpern, WR; Greenblatt, DJ; Miller, LG; Shader, RI1
Armando, I; Barontini, MB; Lemoine, AP; Segura, ET1
Byrnes, JJ; Greenblatt, DJ; Miller, LG; Perkins, K; Shader, RI1
Akhavan, A; Bies, RR; Fafalios, A; McHugh, KJ; Parwani, AV; Pflug, BR1

Other Studies

4 other study(ies) available for lorazepam and pk 11195

ArticleYear
Chronic benzodiazepine administration. X. Concurrent administration of the peripheral-type benzodiazepine ligand PK11195 attenuates chronic effects of lorazepam.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 261, Issue:1

    Topics: Animals; Brain; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Convulsants; Down-Regulation; Flumazenil; Isoquinolines; Ligands; Lorazepam; Male; Mice; Motor Activity; Receptors, GABA-A

1992
The stress-induced reduction in monoamine oxidase (MAO) A activity is reversed by benzodiazepines: role of peripheral benzodiazepine receptors.
    Cellular and molecular neurobiology, 1993, Volume: 13, Issue:6

    Topics: Analysis of Variance; Animals; Brain; Clonazepam; Electroshock; Isoenzymes; Isoquinolines; Lorazepam; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Reference Values; Stress, Psychological

1993
Chronic benzodiazepine administration. XI. Concurrent administration of PK11195 attenuates lorazepam discontinuation effects.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1993, Volume: 8, Issue:3

    Topics: Animals; Benzodiazepinones; Cerebral Cortex; Convulsants; Dose-Response Relationship, Drug; GABA-A Receptor Antagonists; Hippocampus; Isoquinolines; Lorazepam; Male; Mice; Pentylenetetrazole; Seizures; Substance Withdrawal Syndrome

1993
Translocator protein blockade reduces prostate tumor growth.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Oct-01, Volume: 15, Issue:19

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma; Cell Death; Cell Proliferation; Cells, Cultured; Down-Regulation; HeLa Cells; Humans; Isoquinolines; Lorazepam; Male; Mice; Mice, Nude; Prostatic Neoplasms; Receptors, GABA; Tumor Burden; Xenograft Model Antitumor Assays

2009